Skip to content

End of a pharma era

2011, November 30

Today is the end of an era in the pharma industry—the US patent expires on Pfizer’s Lipitor (atorvastatin), the best-selling drug of all time. This drug arguably simultaneously changed both the course of the pharma industry, through the manner of its acquisition by Pfizer, and of human health, through its incontroversially positive  impact on cardiovascular outcomes.

As generic versions go on sale, this will mark LOE (or “loss of exclusivity protection”) of a brand that has dominated the drug industry, lowered the cholesterol of tens of millions of patients, and generated more in annual sales than the entire box office of US movies.

Time then to reflect a little on it and the lessons that it proffers. Two though-provoking pieces…

Why There Will Never Be Another Drug Like Lipitor

Say Farewell to Lipitor but Don’t Forget Its Lessons

From → Science & Pharma

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: